Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 1 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Breast 2Head & Neck 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Melanoma 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × technetium Tc 99m nanocolloid × Clear all
NCT04487912 2021-05-14

Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

University Hospital, Ghent

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT02540551 2020-03-24

SONAR-2

Maastricht University Medical Center

Phase 1 Terminated
11 enrolled
Gynecologic

Ovarian Neoplasms

NCT04261179 2020-02-20

SENTINELSEEK

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Unknown
30 enrolled
BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT01734746 2018-11-05

SONAR

Maastricht University Medical Center

Phase NA Completed
22 enrolled 6 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡